229 related articles for article (PubMed ID: 20971734)
1. Mutant (CCTG)n expansion causes abnormal expression of zinc finger protein 9 (ZNF9) in myotonic dystrophy type 2.
Raheem O; Olufemi SE; Bachinski LL; Vihola A; Sirito M; Holmlund-Hampf J; Haapasalo H; Li YP; Udd B; Krahe R
Am J Pathol; 2010 Dec; 177(6):3025-36. PubMed ID: 20971734
[TBL] [Abstract][Full Text] [Related]
2. Effect of the [CCTG]n repeat expansion on ZNF9 expression in myotonic dystrophy type II (DM2).
Botta A; Caldarola S; Vallo L; Bonifazi E; Fruci D; Gullotta F; Massa R; Novelli G; Loreni F
Biochim Biophys Acta; 2006 Mar; 1762(3):329-34. PubMed ID: 16376058
[TBL] [Abstract][Full Text] [Related]
3. Absence of a differentiation defect in muscle satellite cells from DM2 patients.
Pelletier R; Hamel F; Beaulieu D; Patry L; Haineault C; Tarnopolsky M; Schoser B; Puymirat J
Neurobiol Dis; 2009 Oct; 36(1):181-90. PubMed ID: 19632331
[TBL] [Abstract][Full Text] [Related]
4. The myotonic dystrophy type 2 (DM2) gene product zinc finger protein 9 (ZNF9) is associated with sarcomeres and normally localized in DM2 patients' muscles.
Massa R; Panico MB; Caldarola S; Fusco FR; Sabatelli P; Terracciano C; Botta A; Novelli G; Bernardi G; Loreni F
Neuropathol Appl Neurobiol; 2010 Jun; 36(4):275-84. PubMed ID: 20102514
[TBL] [Abstract][Full Text] [Related]
5. Reduction of the rate of protein translation in patients with myotonic dystrophy 2.
Huichalaf C; Schoser B; Schneider-Gold C; Jin B; Sarkar P; Timchenko L
J Neurosci; 2009 Jul; 29(28):9042-9. PubMed ID: 19605641
[TBL] [Abstract][Full Text] [Related]
6. ZNF9 activation of IRES-mediated translation of the human ODC mRNA is decreased in myotonic dystrophy type 2.
Sammons MA; Antons AK; Bendjennat M; Udd B; Krahe R; Link AJ
PLoS One; 2010 Feb; 5(2):e9301. PubMed ID: 20174632
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of muscle atrophy in myotonic dystrophies.
Timchenko L
Int J Biochem Cell Biol; 2013 Oct; 45(10):2280-7. PubMed ID: 23796888
[TBL] [Abstract][Full Text] [Related]
8. CCUG repeats reduce the rate of global protein synthesis in myotonic dystrophy type 2.
Schneider-Gold C; Timchenko LT
Rev Neurosci; 2010; 21(1):19-28. PubMed ID: 20458885
[TBL] [Abstract][Full Text] [Related]
9. Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy.
Cardani R; Mancinelli E; Sansone V; Rotondo G; Meola G
Eur J Histochem; 2004; 48(4):437-42. PubMed ID: 15718211
[TBL] [Abstract][Full Text] [Related]
10. DM2 intronic expansions: evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expression.
Margolis JM; Schoser BG; Moseley ML; Day JW; Ranum LP
Hum Mol Genet; 2006 Jun; 15(11):1808-15. PubMed ID: 16624843
[TBL] [Abstract][Full Text] [Related]
11. Expanded [CCTG]n repetitions are not associated with abnormal methylation at the CNBP locus in myotonic dystrophy type 2 (DM2) patients.
Santoro M; Fontana L; Maiorca F; Centofanti F; Massa R; Silvestri G; Novelli G; Botta A
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):917-924. PubMed ID: 29291944
[TBL] [Abstract][Full Text] [Related]
12. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24.
Le Ber I; Martinez M; Campion D; Laquerrière A; Bétard C; Bassez G; Girard C; Saugier-Veber P; Raux G; Sergeant N; Magnier P; Maisonobe T; Eymard B; Duyckaerts C; Delacourte A; Frebourg T; Hannequin D
Brain; 2004 Sep; 127(Pt 9):1979-92. PubMed ID: 15215218
[TBL] [Abstract][Full Text] [Related]
13. A role for PLCβ1 in myotonic dystrophies type 1 and 2.
Faenza I; Blalock W; Bavelloni A; Schoser B; Fiume R; Pacella S; Piazzi M; D'Angelo A; Cocco L
FASEB J; 2012 Jul; 26(7):3042-8. PubMed ID: 22459146
[TBL] [Abstract][Full Text] [Related]
14. Colocalization of ribonuclear inclusions with muscle blind like-proteins in a family with myotonic dystrophy type 2 associated with a short CCTG expansion.
Lucchiari S; Pagliarani S; Corti S; Mancinelli E; Servida M; Fruguglietti E; Sansone V; Moggio M; Bresolin N; Comi GP; Meola G
J Neurol Sci; 2008 Dec; 275(1-2):159-63. PubMed ID: 18804219
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a single nucleotide polymorphism in the ZNF9 gene and analysis of association with myotonic dystrophy type II (DM2) in the Italian population.
Vallo L; Bonifazi E; Borgiani P; Novelli G; Botta A
Mol Cell Probes; 2005 Feb; 19(1):71-4. PubMed ID: 15652222
[TBL] [Abstract][Full Text] [Related]
16. Cultured myoblasts from patients affected by myotonic dystrophy type 2 exhibit senescence-related features: ultrastructural evidence.
Malatesta M; Giagnacovo M; Renna LV; Cardani R; Meola G; Pellicciari C
Eur J Histochem; 2011; 55(3):e26. PubMed ID: 22073373
[TBL] [Abstract][Full Text] [Related]
17. Ribonuclear inclusions and MBNL1 nuclear sequestration do not affect myoblast differentiation but alter gene splicing in myotonic dystrophy type 2.
Cardani R; Baldassa S; Botta A; Rinaldi F; Novelli G; Mancinelli E; Meola G
Neuromuscul Disord; 2009 May; 19(5):335-43. PubMed ID: 19345584
[TBL] [Abstract][Full Text] [Related]
18. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
Cho DH; Tapscott SJ
Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
[TBL] [Abstract][Full Text] [Related]
19. Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2.
Cardani R; Giagnacovo M; Botta A; Rinaldi F; Morgante A; Udd B; Raheem O; Penttilä S; Suominen T; Renna LV; Sansone V; Bugiardini E; Novelli G; Meola G
J Neurol; 2012 Oct; 259(10):2090-9. PubMed ID: 22407275
[TBL] [Abstract][Full Text] [Related]
20. A long PCR-based molecular protocol for detecting normal and expanded ZNF9 alleles in myotonic dystrophy type 2.
Bonifazi E; Vallo L; Giardina E; Botta A; Novelli G
Diagn Mol Pathol; 2004 Sep; 13(3):164-6. PubMed ID: 15322428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
